Innoviva (INVA) Cash & Equivalents Growth (1y) (2010 - 2026)
Innoviva (INVA) Cash & Equivalents Growth (1y) (2010 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash & Equiv. Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
988.88% |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
-68.22% |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
0.00% |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
4.77% |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
3.35% |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
269.98% |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
17.50% |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Innoviva |
1.66 Bn |
1.05 Bn |
75.83 Mn |
89.00% |
| Date | Value |
|---|
| Mar 31, 2026 |
89.00% |
| Dec 31, 2025 |
80.66% |
| Sep 30, 2025 |
82.83% |
| Jun 30, 2025 |
83.19% |
| Mar 31, 2025 |
78.91% |
| Dec 31, 2024 |
57.59% |
| Sep 30, 2024 |
44.80% |
| Jun 30, 2024 |
25.42% |
| Mar 31, 2024 |
23.82% |
| Dec 31, 2023 |
-33.51% |
| Sep 30, 2023 |
-40.16% |
| Jun 30, 2023 |
-38.99% |
| Mar 31, 2023 |
-33.56% |
| Dec 31, 2022 |
44.42% |
| Sep 30, 2022 |
122.62% |
| Jun 30, 2022 |
555.45% |
| Mar 31, 2022 |
-23.36% |
| Dec 31, 2021 |
-18.24% |
| Sep 30, 2021 |
-71.80% |
| Jun 30, 2021 |
-89.53% |
